NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Bubs Australia shares surge on infant formula supply deal with Walmart

Published 06/15/2022, 09:53 PM
Updated 06/15/2022, 09:55 PM
© Reuters. FILE PHOTO: A cabinet of baby formulas is seen at a Walmart store in Raleigh, North Carolina, U.S. June 2, 2022. Picture taken June 2, 2022. REUTERS/Arriana Mclymore
AUD/USD
-
WMT
-
KR
-
ABT
-

(Reuters) - Shares of Bubs Australia jumped on Thursday after the company signed a deal to supply its infant formula products to U.S. retail giant Walmart (NYSE:WMT) amid a baby food shortage in the world's largest economy.

Walmart plans to buy a shipment of six Bubs Infant Formula and two Aussie Bubs Toddler Formula products, which would be delivered to about 800 Walmart stores across the United States, Bubs Australia said, adding that the new supply built on its existing online product sales on Walmart.com channel.

Shares of Bubs Australia rose as much as 10.6% to A$0.625 in morning trade, valuing the company at about A$383 million ($268.94 million).

"The addition of Walmart will increase our bricks and mortar exposure in the United States over the coming days and weeks to around 4,800 stores across 35 states," Chief Executive Officer Kristy Carr said.

The 4,800-store footprint includes the first Bubs Australia consignment bought by retailers Kroger (NYSE:KR) and Albertsons.

Bubs Australia recently signed a deal with the U.S. government to supply more than a million tins of infant formula to help the country address the baby food supply crisis.

© Reuters. FILE PHOTO: A cabinet of baby formulas is seen at a Walmart store in Raleigh, North Carolina, U.S. June 2, 2022. Picture taken June 2, 2022. REUTERS/Arriana Mclymore

The crisis was triggered when Abbott Laboratories (NYSE:ABT) recalled dozens of its brands in February after consumers complained of infants contracting bacterial infections.

($1 = 1.4241 Australian dollars)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.